Dergiler / Journal of Clinical Research in Pediatric Endocrinology / 2017 / Cilt: 9 - Sayı: 2

Heart-Type Fatty Acid Binding Protein Level as a Tool in Identification of Early Cardiac Effects of Diabetic Ketoacidosis

Sayfa
118–123
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The H-FABP value of the DKA group was also found to be significantly higher than the value at hour 36 after acidosis correction (p=0.0001).Conclusion: We would like to propose H-FABP as a potential marker for indicating myocardial ischemia.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: This study aimed to measure the serum levels of heart-type fatty acid binding protein (H-FABP) in patients presenting with diabetic ketoacidosis (DKA) and diabetic ketosis (DK) and to determine its role in identifying early-period cardiac ischemia.Methods: This prospective study included 35 patients diagnosed with DKA, 20 patients diagnosed with DK, and 20 control subjects.
📊
Temel Bulgular & Veri:H-FABP values were measured again after acidosis correction in the DKA patients.Results: No statistically significant differences were found with respect to troponin I and CK-MB within the groups.
💡
Sonuç & Katkı:The H-FABP value of the DKA group was also found to be significantly higher than the value at hour 36 after acidosis correction (p=0.0001).Conclusion: We would like to propose H-FABP as a potential marker for indicating myocardial ischemia.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: This study aimed to measure the serum levels of heart-type fatty acid binding protein (H-FABP) in patients presenting with diabetic ketoacidosis (DKA) and diabetic ketosis (DK) and to determine its role in identifying early-period cardiac ischemia.Methods: This prospective study included 35 patients diagnosed with DKA, 20 patients diagnosed with DK, and 20 control subjects. H-FABP, creatine kinase-MB (CK-MB), and troponin I levels were investigated at presentation in patients with DKA and DK and in the control group. H-FABP values were measured again after acidosis correction in the DKA patients.Results: No statistically significant differences were found with respect to troponin I and CK-MB within the groups. The H-FABP values of DKA patients at presentation were found to be significantly higher than those of DK patients and the control group (p=0.015). The H-FABP value of the DKA group was also found to be significantly higher than the value at hour 36 after acidosis correction (p=0.0001).Conclusion: We would like to propose H-FABP as a potential marker for indicating myocardial ischemia.

🔖

Bu Makaleye Atıf Yap

YILMAZ, F. H., ARI, S. Y., VATANSEV, H., CİMBEK, E. A., ŞEN, Y., YILMAZ, İ., AKYÜREK, F., ARSLAN, D., ÇİMEN, D., YORULMAZ, A. (2017). Heart-Type Fatty Acid Binding Protein Level as a Tool in Identification of Early Cardiac Effects of Diabetic Ketoacidosis. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 9 - Sayı: 2, 118–123. https://ajindex.com/articles/270481

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Dabelea D, Rewers A, Stafford JM, Standiford DA, Lawrence JM, Saydah S, Imperatore G, D'Agostino RB Jr, Mayer-Davis EJ, Pihoker C; SEARCH for Diabetes in Youth Study Group. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133:938-945. Raghupathy P. Diabetic ketoacidosis in children and adolescents. Indian J Endocrinol Metab 2015;19(Supp1):55-57.
  2. Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral edema developing during diabetic ketoacidosis. Arch Dis Child 2001;85:16-22.
  3. Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee WW, Rosenbloom A, Sperking MA, Hanas R. Diabetic ketoacidosis. Pediatr Diabetes 2007;8(Suppl1):28-43.
  4. Sohmiya K, Tanaka T, Tsuji R, Yoshimoto K, Nakayama Y, Hirota Y, Kawamura K, Matsunaga Y, Nishimura S, Miyazaki H. Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol 1993;25:1413-1426.
  5. Nakata T, Hashimoto A, Hase M, Tsuchihashi K, Shimamoto K. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 2003;99:96-104.
  6. Ruzgar O, Bilge AK, Bugra Z, Umman S, Yilmaz E, Ozben B, Umman B, Meric M. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band. Heart Vessels 2006;21:309-314. Epub 2006 Sep 29 Aartsen WM, Pelsers MM, Hermens WT, Glatz JF, Daemen MJ, Smits JF. Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice. Pflugers Arch 2000;439:416-422.
  7. Pelsers MM, Hermens WT, Glatz JF. Fatty acid binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005;352:15-35.
  8. Atabek ME, Pirgon O, Oran B, Erkul I, Kurtoglu S. Increased cardiac troponin I concentration in diabetic ketoacidosis. J Pediatr Endocrinol Metab 2004;17:1077-1082.
  9. Hoffman WH, Sharma M, Cihakova D, Talor MV, Rose NR, Mohanakumar T, Passmore GG. Cardiac antibody production to self-antigens in children and adolescents during and following the correction of severe diabetic ketoacidosis. Autoimmunity 2016;49:188-196. Epub 2016 Feb 25 Van Nieuwenhoven FA, Kleine AH, Wodzing WH, Hermens WT, Kragten HA, Maessen JG, Punt CD, Van Diei